Market Data
Market Cap₹1,280.47 Cr.
52W High₹175
Current Price₹156.05
52W Low₹114
Down from 52W High10.8 %
Face Value₹10
Performance
ROCE27.44 %
ROE29.88 %
EPS (TTM)₹1.55
EPS Prev Qtr₹1.78
EPS Last Year₹1.29
EBITDA Qtr₹17.3 Cr.
Book Value₹19
Financial Health
Debt/Equity0.6
Debt/Profit2.02
Total Assets₹323.224 Cr.
Promoter Holding65.57 %
Earning Power19.56 %
Valuation
Stock P/E27.09
Industry P/E40.99
Price to Book8.09
Price to Sales2.6
Graham Number₹50
Key Metrics
Face Value
₹10
About GPT Healthcare Ltd
Healthcare · Healthcare
GPT Healthcare Ltd is listed on NSE in the Healthcare / Healthcare sector. Face value ₹10. Market cap ₹1,280.47 Cr.
Price Chart
Strengths & Weaknesses
Strengths
- The company has a strong Return on Equity (ROE) of 29.88%, indicating efficient use of shareholder equity.
- The Return on Capital Employed (ROCE) is 27.44%, reflecting good capital efficiency.
- The company maintains a moderate debt-to-equity ratio of 0.6, suggesting a balanced capital structure.
- The promoter holding stands at 65.57%, indicating significant management control and alignment of interests.
Weaknesses
- The P/E ratio of 28.01 may indicate that the stock is relatively expensive compared to earnings.
- The P/B ratio of 8.37 suggests that the market values the company at a premium over its book value.
- The dividend yield is not available, indicating that the company may not currently pay dividends.
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | - | 60.97 | ₹1,27,421.96 Cr | 0.23% | ₹2,172 Cr | - | ₹26,429.9 Cr | - | 22.05% | 0.6 |
| Max Healthcare Institute Ltd | - | 66.77 | ₹97,411.97 Cr | 0.2% | ₹1,457.4 Cr | - | ₹8,712.05 Cr | - | 14.38% | 0.27 |
| Manipal Health Enterprises Ltd | - | - | ₹94,970.23 Cr | - | - | - | - | - | - | 1.25 |
| Aster DM Quality Care Ltd | - | 121 | ₹65,183.66 Cr | 0.4% | ₹362.82 Cr | - | ₹4,876.03 Cr | - | 12.95% | 0.17 |
| Fortis Healthcare Ltd | - | 59.91 | ₹62,782.32 Cr | 0.12% | ₹1,070.21 Cr | - | ₹9,506.15 Cr | - | 13.34% | 0.29 |
| Global Health Ltd | - | 69.27 | ₹38,550.84 Cr | - | ₹552.33 Cr | - | ₹4,683.41 Cr | - | 21.87% | 0.1 |
| Narayana Hrudayalaya Ltd | - | 45.26 | ₹37,159.95 Cr | - | ₹816.55 Cr | - | ₹9,072.4 Cr | - | 13.65% | 1.07 |
| Dr Lal Pathlabs Ltd | - | 46.81 | ₹32,548.55 Cr | 1.26% | ₹546.3 Cr | - | ₹2,890.8 Cr | - | 29.55% | 0 |
| Krishna Institute of Medical Sciences Ltd | - | 150.24 | ₹32,180.9 Cr | - | ₹194.4 Cr | - | ₹4,212.5 Cr | - | 9.66% | 1.44 |
| Poly Medicure Ltd | - | 52.64 | ₹16,587.48 Cr | 0.21% | ₹312.92 Cr | - | ₹1,997.43 Cr | - | 15.07% | 0.06 |
| Dr Agarwals Health Care Ltd | - | 107.57 | ₹15,991.79 Cr | - | ₹185.1 Cr | - | ₹2,206.68 Cr | - | 16.46% | 0.08 |
| Vijaya Diagnostic Centre Ltd | - | 82.27 | ₹15,431.94 Cr | 0.13% | ₹187.49 Cr | - | ₹857.13 Cr | - | 36.21% | 0 |
| Syngene International Ltd | - | 68.32 | ₹15,167.87 Cr | 0.33% | ₹221 Cr | - | ₹3,600.2 Cr | - | 6.95% | 0 |
| Indegene Ltd | - | 36.68 | ₹14,769.29 Cr | 0.37% | ₹400.9 Cr | - | ₹3,812.8 Cr | - | 17.45% | 0 |
| Rainbow Childrens Medicare Ltd | - | 48.85 | ₹13,947.12 Cr | 0.25% | ₹290.28 Cr | - | ₹1,820.14 Cr | - | 27.05% | 0 |
| Molbio Diagnostics Ltd | - | - | ₹13,924.73 Cr | - | - | - | - | - | - | 0.35 |
| Park Medi World Ltd | - | 38.3 | ₹11,945.05 Cr | - | ₹296.75 Cr | - | ₹1,756.29 Cr | - | 19.17% | 0.11 |
| Metropolis Healthcare Ltd | - | 24.51 | ₹11,863.54 Cr | 0.87% | ₹202.82 Cr | - | ₹1,710 Cr | - | 19.8% | 0.01 |
| Yatharth Hospital & Trauma Care Services Ltd | - | 58.5 | ₹10,596.57 Cr | - | ₹174.45 Cr | - | ₹1,334.1 Cr | - | 11.7% | 0.14 |
| Healthcare Global Enterprises Ltd | - | 446.68 | ₹10,336.94 Cr | - | ₹33.26 Cr | - | ₹2,627.35 Cr | - | 9.41% | 0.68 |
Quarterly Results
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales | 118.91 | 120.16 | 126.37 | 126.2 |
| ↳ QoQ Growth | - | +1.1% | +5.2% | -0.1% |
| Expenses | 103.01 | 106.56 | 109.95 | 108.9 |
| Operating Profit | 15.89 | 13.6 | 16.42 | 17.3 |
| OPM % | 13.36% | 11.32% | 12.99% | 13.71% |
| Other Income | 1.34 | 1.42 | 1.63 | 2.03 |
| Interest | 2.16 | 2.26 | 2.18 | 2.16 |
| Depreciation | 6.85 | 7.11 | 6.95 | 6.88 |
| EBITDA | 22.74 | 20.71 | 23.37 | 24.18 |
| EBITDA Margin % | 19.12% | 17.24% | 18.49% | 19.16% |
| Profit Before Tax | 15.07 | 12.76 | 15.86 | 17.16 |
| Tax % | 29.66% | 26.57% | 8.2% | 25.82% |
| Net Profit | 10.6 | 9.37 | 14.57 | 12.73 |
| ↳ QoQ Growth | - | -11.6% | +55.5% | -12.6% |
| EPS | 1.29 | 1.14 | 1.78 | 1.55 |
Balance Sheet
| Mar 2022 | |
|---|---|
| Equity Capital | 79.9043 |
| Reserves | 78.2782 |
| Borrowings | 95.52 |
| Other Liabilities | 69.52 |
| Total Liabilities | 323.2236 |
| Fixed Assets | 220.1928 |
| CWIP | 0.7183 |
| Investments | 10.39 |
| Other Assets | 91.92 |
| Total Assets | 323.2236 |
Cash Flows
| Mar 2022 | |
|---|---|
| Cash from Operating Activity | 65.9918 |
| Cash from Investing Activity | -5.3394 |
| Cash from Financing Activity | -57.1605 |
| Net Cash Flow | 3.4919 |
Shareholding Pattern
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters % | 65.57% | 65.57% | 65.57% | 65.57% |
| FIIs % | 3.2% | 2.74% | 2.81% | 3.03% |
| DIIs % | 6.45% | 6.2% | 6.84% | 6.94% |
| Public % | 18.89% | 19.11% | 18.33% | 18.01% |
| No. of Shareholders | 67,617 | 66,626 | 64,075 | 62,454 |
Major Shareholders (>1%)
- Gpt Sons Private LimitedPromoter and Promoter Group65.57%
- Bandhan Small Cap FundPublic Shareholding4.65%
- India Capital Growth Fund LimitedPublic Shareholding2.74%
- Rajasthan Global Securities Private LimitedPublic Shareholding1.20%
As of 2026-06-30View all shareholders →